Display options
Cite
Herminghaus A, Eberhardt R, Truse R, et al. Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers. Front Med (Lausanne). 2018;5:291doi: 10.3389/fmed.2018.00291.
Herminghaus, A., Eberhardt, R., Truse, R., Schulz, J., Bauer, I., Picker, O., & Vollmer, C. (2018). Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers. Frontiers in medicine, 5291. https://doi.org/10.3389/fmed.2018.00291
Herminghaus, Anna, et al. "Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers." Frontiers in medicine vol. 5 (2018): 291. doi: https://doi.org/10.3389/fmed.2018.00291
Herminghaus A, Eberhardt R, Truse R, Schulz J, Bauer I, Picker O, Vollmer C. Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers. Front Med (Lausanne). 2018 Oct 16;5:291. doi: 10.3389/fmed.2018.00291. eCollection 2018. PMID: 30460235; PMCID: PMC6232762.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2018 Oct 16;5:291. doi: 10.3389/fmed.2018.00291. eCollection 2018.

Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers.

Frontiers in medicine

Anna Herminghaus, Rebecca Eberhardt, Richard Truse, Jan Schulz, Inge Bauer, Olaf Picker, Christian Vollmer

Affiliations

  1. Department of Anaesthesiology, University of Düsseldorf, Düsseldorf, Germany.

PMID: 30460235 PMCID: PMC6232762 DOI: 10.3389/fmed.2018.00291

Abstract

Locally applied nitroglycerin [nitric oxide (NO) donor] and iloprost (analog of prostacyclin PGI

Keywords: Caco-2 cells; barrier function; iloprost; mitochondrial respiration; nitroglycerin

References

  1. Am J Physiol. 1994 Apr;266(4 Pt 1):G633-46 - PubMed
  2. J Emerg Trauma Shock. 2011 Apr;4(2):233-43 - PubMed
  3. J Clin Invest. 1990 Apr;85(4):1127-34 - PubMed
  4. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):819-22 - PubMed
  5. Eur J Clin Invest. 2013 May;43(5):532-42 - PubMed
  6. Microcirculation. 2017 May;24(4): - PubMed
  7. Am J Physiol. 1995 Oct;269(4 Pt 2):R848-55 - PubMed
  8. Am J Pathol. 2013 Dec;183(6):1871-1884 - PubMed
  9. J Biochem Mol Toxicol. 2011 Sep-Oct;25(5):297-302 - PubMed
  10. FEBS Lett. 1995 Aug 7;369(2-3):136-9 - PubMed
  11. Tohoku J Exp Med. 1986 Dec;150(4):373-9 - PubMed
  12. Free Radic Biol Med. 2010 Sep 1;49(5):777-85 - PubMed
  13. J Mol Cell Cardiol. 1988 Dec;20(12):1095-106 - PubMed
  14. Shock. 2016 Mar;45(3):271-81 - PubMed
  15. Mol Med. 2010 Jul-Aug;16(7-8):254-61 - PubMed
  16. Cell Biol Toxicol. 2005 Jan;21(1):1-26 - PubMed
  17. Crit Care Med. 2011 Sep;39(9):2087-98 - PubMed
  18. Am J Physiol. 1995 Feb;268(2 Pt 1):G361-73 - PubMed
  19. J Vasc Res. 2017;54(2):109-121 - PubMed
  20. Curr Opin Anaesthesiol. 2009 Apr;22(2):184-90 - PubMed
  21. Gastroenterology. 1989 Mar;96(3):736-49 - PubMed
  22. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  23. Am J Physiol. 1994 Feb;266(2 Pt 1):G222-9 - PubMed
  24. Endocrinology. 2014 Feb;155(2):370-9 - PubMed
  25. Biochim Biophys Acta. 2004 Jul 23;1658(1-2):44-9 - PubMed

Publication Types